Literature DB >> 28299245

Medical Big Data for Research Use: Current Status and Related Issues.

Koichi Benjamin Ishikawa1.   

Abstract

Advances in the computerization of information and development of technology have mitigated restrictions on handling of a large amount of information. This has resulted in growth of expectations for the use of large-scale databases, or so-called "big data." This is also the case in the field of healthcare. Projects that involve building of the national receipt database (NDB) of medical fee bill (receipt) information and special health check-up information based on the Act on Assurance of Medical Care for Elderly People and the development of medical information databases have been pursued by the national government, and considerable attention has also been focused on researches conducted through the secondary uses of publicly collected data. Aside from these trends, there are numerous projects which collect diagnosis procedure combination (DPC) data to build large-scale databases for research purposes. Following to the ethics guidelines for epidemiologic studies, they collect and analyze anonymized DPC data from cooperating institutions. This communication concentrates on the use of DPC data, and outlines the scale of data currently available for research use. Examples on the use of DPC data will be shown for analysis on the current status of clinical practice from the microscopic perspective and macroscopic analysis of community medical care provision. Additionally, potential for extending studies to long-term outcomes research, limitations and issues related to the use of medical big data will also be discussed.

Entities:  

Keywords:  Clinical processes; Community care provision; DPC data; Large-scale medical databases; Open data

Year:  2016        PMID: 28299245      PMCID: PMC5333614     

Source DB:  PubMed          Journal:  Japan Med Assoc J        ISSN: 1346-8650


  7 in total

Review 1.  Road to comprehensive estimation of antimicrobial resistance (AMR) disease burden in Japan.

Authors:  Shinya Tsuzuki; Nobuaki Matsunaga; Norio Ohmagari
Journal:  Glob Health Med       Date:  2020-06-30

2.  Lipid-lowering drugs and risk of new-onset diabetes: a cohort study using Japanese healthcare data linked to clinical data for health screening.

Authors:  Nobuhiro Ooba; Soko Setoguchi; Tsugumichi Sato; Kiyoshi Kubota
Journal:  BMJ Open       Date:  2017-06-30       Impact factor: 2.692

3.  Early administration of glucocorticoid for thyroid storm: analysis of a national administrative database.

Authors:  Atsushi Senda; Akira Endo; Hisateru Tachimori; Kiyohide Fushimi; Yasuhiro Otomo
Journal:  Crit Care       Date:  2020-07-29       Impact factor: 9.097

4.  Machine learning-based model for predicting 1 year mortality of hospitalized patients with heart failure.

Authors:  Takeshi Tohyama; Tomomi Ide; Masataka Ikeda; Hidetaka Kaku; Nobuyuki Enzan; Shouji Matsushima; Kouta Funakoshi; Junji Kishimoto; Koji Todaka; Hiroyuki Tsutsui
Journal:  ESC Heart Fail       Date:  2021-08-13

Review 5.  Context and Considerations for Use of Two Japanese Real-World Databases in Japan: Medical Data Vision and Japanese Medical Data Center.

Authors:  Thomas Laurent; Jason Simeone; Ryohei Kuwatsuru; Takahiro Hirano; Sophie Graham; Ryozo Wakabayashi; Robert Phillips; Tatsuya Isomura
Journal:  Drugs Real World Outcomes       Date:  2022-03-18

6.  Effects of the different periods and magnitude of COVID-19 infection spread on cancer operations: Interrupted time series analysis of medical claims data.

Authors:  Natsue Kashiwagura; Fuyuhiko Motoi; Upul Cooray; Ryu Fukase; Yukiko Katayama; Ken Osaka; Masayasu Murakami; Takaaki Ikeda
Journal:  Cancer Med       Date:  2022-09-20       Impact factor: 4.711

7.  Treatment patterns and adherence to antihypertensive combination therapies in Japan using a claims database.

Authors:  Takayuki Ishida; Akinori Oh; Shinzo Hiroi; Yukio Shimasaki; Nobuhiro Nishigaki; Takuya Tsuchihashi
Journal:  Hypertens Res       Date:  2018-11-16       Impact factor: 3.872

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.